393 Results

People

  1. Perales
    Perales
  2. Giralt
    Giralt
  3. Shouval
    Shouval
  4. Shah
    Shah
  5. Nelson
    Nelson
  6. Park
    Park
  7. Scordo
    Scordo
  8. Dahi
    Dahi
  9. Jones
    Jones
  10. Mehrara
    Mehrara

Groups

  1. Department of Medicine (175)
  2. Surgery (101)
  3. Survivorship Research (98)
  4. Hematologic Malignancies, Division of (92)
  5. Center for Hematologic Malignancies (78)
  6. Sloan Kettering Institute Postdocs (66)
  7. Solid Tumor Oncology Division (66)
  8. Population Sciences Research Program (60)
  9. Division of Subspecialty Medicine (57)
  10. Epidemiology and Biostatistics (57)
  1. "adverse event"
Formats
  1. Journal Article (266)
  2. Review (75)
  3. Editorial (17)
  4. Guidelines (11)
  5. Research Letter (11)
  6. Correspondence (8)
  7. Conference Paper (2)
  8. Miscellaneous (2)
  9. Meeting Abstract (1)
Groups
  1. Department of Medicine (175)
  2. Surgery (101)
  3. Survivorship Research (98)
  4. Hematologic Malignancies, Division of (92)
  5. Center for Hematologic Malignancies (78)
  6. Sloan Kettering Institute Postdocs (66)

More Groups

People
  1. Miguel-Angel Perales (32)
  2. Sergio Giralt (20)
  3. Sean Devlin (17)
  4. Jonas Nelson (14)
  5. Roni Shouval (13)
  6. Gunjan Shah (12)

More People

Years
  1. 2025 (62)
  2. 2024 (100)
  3. 2023 (62)
  4. 2022 (106)
  5. 2021 (15)
  6. 2020 (17)

More Years

Publications
  1. Transplantation and Cellular Therapy (26)
  2. Journal of Clinical Oncology (17)
  3. Clinical Cancer Research (11)
  4. International Journal of Radiation Oncology, Biology, Physics (11)
  5. Annals of Surgical Oncology (10)
  6. Plastic and Reconstructive Surgery (10)

More Publications

Publishers
  1. Elsevier Inc. (76)
  2. Springer (39)
  3. Elsevier Science, Inc. (34)
  4. Nature Publishing Group (25)
  5. Lippincott Williams & Wilkins (23)
  6. American Society of Clinical Oncology (18)

More Publishers

Results (393)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Dermatologic toxicities to immune checkpoint inhibitor therapy: A review of histopathologic features
    Review

    Ellis, S. R.; Vierra, A. T.; Millsop, J. W.; Lacouture, M. E.; Kiuru, M.
    Journal of the American Academy of Dermatology (2020)

    Fulltext@MSK | Save
  • Peptide receptor radionuclide therapy during the COVID-19 pandemic: Are there any concerns?
    Correspondence

    Bodei, L.; Bergsland, E.; de Herder, W. W.; Ferone, D.; Hicks, R. J.; Hope, T. A.; Kunikowska, J.; Pavel, M.; Reidy-Lagunes, D.; Siveke, J.; more...
    Journal of Nuclear Medicine (2020)

    Fulltext@MSK | Save
  • Time-varying analysis of readmission and mortality during the first year after pneumonectomy
    Conference Paper

    Jones, G. D.; Tan, K. S.; Caso, R.; Dycoco, J.; Park, B. J.; Bott, M. J.; Molena, D.; Huang, J.; Isbell, J. M.; Bains, M. S.; more...
    Mosby Elsevier (2020)

    Fulltext@MSK | Save
  • Carfilzomib, dexamethasone, and daratumumab versus carfilzomib and dexamethasone for patients with relapsed or refractory multiple myeloma (CANDOR): Results from a randomised, multicentre, open-label, phase 3 study
    Journal Article

    Dimopoulos, M.; Quach, H.; Mateos, M. V.; Landgren, O.; Leleu, X.; Siegel, D.; Weisel, K.; Yang, H.; Klippel, Z.; Zahlten-Kumeli, A.; more...
    Lancet (2020)

    Fulltext@MSK | Save
  • Dermatologic adverse events related to the PI3Kα inhibitor alpelisib (BYL719) in patients with breast cancer
    Journal Article

    Wang, D. G.; Barrios, D. M.; Blinder, V. S.; Bromberg, J. F.; Drullinsky, P. R.; Funt, S. A.; Jhaveri, K. L.; Lake, D. E.; Lyons, T.; Modi, S.; more...
    Breast Cancer Research and Treatment (2020)

    Fulltext@MSK | Save
  • Tocilizumab not associated with increased infection risk after CAR T-cell therapy: Implications for COVID-19?
    Research Letter

    Frigault, M. J.; Nikiforow, S.; Mansour, M. K.; Hu, Z. H.; Horowitz, M. M.; Riches, M. L.; Hematti, P.; Turtle, C. J.; Zhang, M. J.; Perales, M. A.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • The combination of ibrutinib and rituximab demonstrates activity in first-line follicular lymphoma
    Journal Article

    Fowler, N. H.; Nastoupil, L.; De Vos, S.; Knapp, M.; Flinn, I. W.; Chen, R.; Advani, R. H.; Bhatia, S.; Martin, P.; Mena, R.; more...
    British Journal of Haematology (2020)

    Fulltext@MSK | Save
  • Core outcome set for actinic keratosis clinical trials
    Journal Article

    Reynolds, K. A.; Schlessinger, D. I.; Vasic, J.; Iyengar, S.; Qaseem, Y.; Behshad, R.; DeHoratius, D. M.; Denes, P.; Drucker, A. M.; Dzubow, L. M.; more...
    JAMA Dermatology (2020)

    Fulltext@MSK | Save
  • Rate and risk factors for wound complications after internal hemipelvectomy
    Journal Article

    Ogura, K.; Boland, P. J.; Fabbri, N.; Healey, J. H.
    Bone & Joint Journal (2020)

    Fulltext@MSK | Save
  • Risk of pelvic fracture with radiation therapy in older patients
    Journal Article

    Vitzthum, L. K.; Park, H.; Zakeri, K.; Heide, E. S.; Nalawade, V.; Mundt, A. J.; Vaida, F.; Murphy, J. D.; Mell, L. K.
    International Journal of Radiation Oncology, Biology, Physics (2020)

    Fulltext@MSK | Save